239 related articles for article (PubMed ID: 18564343)
1. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus.
Schepis D; Gunnarsson I; Eloranta ML; Lampa J; Jacobson SH; Kärre K; Berg L
Immunology; 2009 Jan; 126(1):140-6. PubMed ID: 18564343
[TBL] [Abstract][Full Text] [Related]
2. Activation status of CD56
Liu M; Liu J; Zhang X; Xiao Y; Jiang G; Huang X
Clin Rheumatol; 2021 Mar; 40(3):1103-1112. PubMed ID: 32797360
[TBL] [Abstract][Full Text] [Related]
3. Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression.
Zahran AM; Abdel-Rahim MH; Elsayh KI; Hassanien MM; Mahran SA; Hetta HF
Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):161-169. PubMed ID: 30944972
[TBL] [Abstract][Full Text] [Related]
4. NK cells dysfunction in systemic lupus erythematosus: relation to disease activity.
Henriques A; Teixeira L; Inês L; Carvalheiro T; Gonçalves A; Martinho A; Pais ML; da Silva JA; Paiva A
Clin Rheumatol; 2013 Jun; 32(6):805-13. PubMed ID: 23377197
[TBL] [Abstract][Full Text] [Related]
5. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
[TBL] [Abstract][Full Text] [Related]
6. [Interferon-α mediating the functional damage of CD56
Zhao XG; Liu JQ; Huang HN; Lu ZM; Bai ZR; Li X; Qi JJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):975-981. PubMed ID: 38101777
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic Function and Cytokine Production of Natural Killer Cells and Natural Killer T-Like Cells in Systemic Lupus Erythematosis Regulation with Interleukin-15.
Lin SJ; Kuo ML; Hsiao HS; Lee PT; Lee WI; Chen JY; Huang JL
Mediators Inflamm; 2019; 2019():4236562. PubMed ID: 31049024
[TBL] [Abstract][Full Text] [Related]
8. Interferon-γ production by tubulointerstitial human CD56
Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
[TBL] [Abstract][Full Text] [Related]
9. Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases.
Puxeddu I; Bongiorni F; Chimenti D; Bombardieri S; Moretta A; Bottino C; Migliorini P
Scand J Rheumatol; 2012 Aug; 41(4):298-304. PubMed ID: 22632143
[TBL] [Abstract][Full Text] [Related]
10. Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15.
Lin SJ; Kuo ML; Hsiao HS; Lee PT; Chen JY; Huang JL
PLoS One; 2017; 12(10):e0186223. PubMed ID: 29023581
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in systemic lupus erythematosus.
Hudspeth K; Wang S; Wang J; Rahman S; Smith MA; Casey KA; ; Manna Z; Sanjuan M; Kolbeck R; Hasni S; Ettinger R; Siegel RM
Clin Exp Immunol; 2019 May; 196(2):226-236. PubMed ID: 30693467
[TBL] [Abstract][Full Text] [Related]
12. Increased oxidative stress contributes to impaired peripheral CD56
Lu Z; Tian Y; Bai Z; Liu J; Zhang Y; Qi J; Jin M; Zhu J; Li X
Arthritis Res Ther; 2022 Feb; 24(1):48. PubMed ID: 35172900
[TBL] [Abstract][Full Text] [Related]
13. Role of IL-24 in NK cell activation and its clinical implication in systemic lupus erythematosus.
Tang Y; Sun X; Wang Y; Luan H; Zhang R; Hu F; Sun X; Li X; Guo J
Clin Rheumatol; 2021 Jul; 40(7):2707-2715. PubMed ID: 33534028
[TBL] [Abstract][Full Text] [Related]
14. Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus.
Hervier B; Ribon M; Tarantino N; Mussard J; Breckler M; Vieillard V; Amoura Z; Steinle A; Klein R; Kötter I; Decker P
Front Immunol; 2021; 12():633658. PubMed ID: 34012432
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the regulatory function of natural killer cells from patients with systemic lupus erythematosus.
Cruz-González DJ; Gómez-Martin D; Layseca-Espinosa E; Baranda L; Abud-Mendoza C; Alcocer-Varela J; González-Amaro R; Monsiváis-Urenda AE
Clin Exp Immunol; 2018 Mar; 191(3):288-300. PubMed ID: 29058308
[TBL] [Abstract][Full Text] [Related]
16. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
[TBL] [Abstract][Full Text] [Related]
17. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
Front Immunol; 2021; 12():640672. PubMed ID: 34017328
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of natural killer activating and inhibitory receptors in patients with newly diagnosed systemic lupus erythematosus.
Ye Z; Ma N; Zhao L; Jiang ZY; Jiang YF
Int J Rheum Dis; 2016 Jun; 19(6):613-21. PubMed ID: 24617980
[TBL] [Abstract][Full Text] [Related]
19. CD56
Shi A; Zhang X; Xiao F; Zhu L; Yan W; Han M; Luo X; Chen T; Ning Q
J Viral Hepat; 2018 Nov; 25(11):1352-1362. PubMed ID: 29888839
[TBL] [Abstract][Full Text] [Related]
20. The phenotype of CD3-CD56
Soelistyoningsih D; Susianti H; Kalim H; Handono K
Reumatologia; 2022; 60(4):258-265. PubMed ID: 36186836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
